114 related articles for article (PubMed ID: 9178568)
21. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
22. Biological activity of alpha-thujaplicin, the minor component of Thujopsis dolabrata SIEB. et ZUCC. var. hondai MAKINO.
Morita Y; Matsumura E; Tsujibo H; Yasuda M; Sakagami Y; Okabe T; Ishida N; Inamori Y
Biol Pharm Bull; 2001 Jun; 24(6):607-11. PubMed ID: 11411545
[TBL] [Abstract][Full Text] [Related]
23. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
[TBL] [Abstract][Full Text] [Related]
25. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and antibacterial activities of neomycin-lipid conjugates: polycationic lipids with potent gram-positive activity.
Bera S; Zhanel GG; Schweizer F
J Med Chem; 2008 Oct; 51(19):6160-4. PubMed ID: 18778047
[TBL] [Abstract][Full Text] [Related]
27. Effects of zinc oxide on the attachment of Staphylococcus aureus strains.
Akiyama H; Yamasaki O; Kanzaki H; Tada J; Arata J
J Dermatol Sci; 1998 May; 17(1):67-74. PubMed ID: 9651831
[TBL] [Abstract][Full Text] [Related]
28. Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.
Russell CC; Stevens A; Pi H; Khazandi M; Ogunniyi AD; Young KA; Baker JR; McCluskey SN; Page SW; Trott DJ; McCluskey A
ChemMedChem; 2018 Dec; 13(23):2573-2580. PubMed ID: 30318716
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.
Ling TK; Liu EY; Cheng AF
Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of seed proteins of Robinia pseudoacacia.
Talas-Oğraş T; Ipekçi Z; Bajroviç K; Gözükirmizi N
Fitoterapia; 2005 Jan; 76(1):67-72. PubMed ID: 15664465
[TBL] [Abstract][Full Text] [Related]
31. Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.
Qadri SM; Ueno Y; Postle G; Tullo D; San Pedro J
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):372-7. PubMed ID: 8394816
[TBL] [Abstract][Full Text] [Related]
32. Biological activity of 4-acetyltropolone, the minor component of Thujopsis dolabrata SIeb. et Zucc. hondai Mak.
Morita Y; Matsumura E; Tsujibo H; Yasuda M; Okabe T; Sakagami Y; Kumeda Y; Ishida N; Inamor Y
Biol Pharm Bull; 2002 Aug; 25(8):981-5. PubMed ID: 12186430
[TBL] [Abstract][Full Text] [Related]
33. [Antimicrobial activity of organic extracts isolated from Aplysina fistularis (Demospongiae: Aplysinidae)].
Morales T; Cubero J; Lanz Z; Gómez-Guiñán Y; Segnini-Bravo MI
Rev Biol Trop; 2000 Dec; 48 Suppl 1():199-206. PubMed ID: 15266809
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Farrell DJ; Robbins M; Rhys-Williams W; Love WG
Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
[TBL] [Abstract][Full Text] [Related]
36. Antibacterial activity of Acalypha indica L.
Govindarajan M; Jebanesan A; Reetha D; Amsath R; Pushpanathan T; Samidurai K
Eur Rev Med Pharmacol Sci; 2008; 12(5):299-302. PubMed ID: 19024213
[TBL] [Abstract][Full Text] [Related]
37. Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.
Yu WY; Yang LX; Xie JS; Zhou L; Jiang XY; Zhu DX; Muramatsu M; Wang MW
Acta Pharmacol Sin; 2008 Feb; 29(2):267-77. PubMed ID: 18215358
[TBL] [Abstract][Full Text] [Related]
38. Antibacterial and cytotoxic activity of Kenyan medicinal plants.
Cyrus WG; Daniel GW; Nanyingi MO; Njonge FK; Mbaria JM
Mem Inst Oswaldo Cruz; 2008 Nov; 103(7):650-2. PubMed ID: 19057813
[TBL] [Abstract][Full Text] [Related]
39. New insights on the antibacterial efficacy of miconazole in vitro.
Nenoff P; Koch D; Krüger C; Drechsel C; Mayser P
Mycoses; 2017 Aug; 60(8):552-557. PubMed ID: 28370366
[TBL] [Abstract][Full Text] [Related]
40. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
